MaxCyte, Inc.
MXCT
$1.41
$0.0151.08%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -18.12% | 19.52% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -18.12% | 19.52% | |||
| Cost of Revenue | 1.47% | -34.37% | |||
| Gross Profit | -21.42% | 38.69% | |||
| SG&A Expenses | -2.52% | 3.98% | |||
| Depreciation & Amortization | 1.79% | 4.02% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.22% | 5.05% | |||
| Operating Income | -15.71% | 4.70% | |||
| Income Before Tax | -20.43% | 3.17% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -20.43% | 3.17% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -20.43% | 3.17% | |||
| EBIT | -15.71% | 4.70% | |||
| EBITDA | -17.22% | 5.45% | |||
| EPS Basic | -19.94% | 3.59% | |||
| Normalized Basic EPS | -20.00% | 3.66% | |||
| EPS Diluted | -19.94% | 3.59% | |||
| Normalized Diluted EPS | -20.00% | 3.66% | |||
| Average Basic Shares Outstanding | 0.43% | 0.38% | |||
| Average Diluted Shares Outstanding | 0.43% | 0.38% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||